Journal article · 2021 · Open access
Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices
Neuropharmacology, 201, 108833 · Published 11 October 2021 · DOI 10.1016/j.neuropharm.2021.108833
In brief
“Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices” is a 2021 journal article by Alen V. Eapen and 7 co-authors, published in Neuropharmacology. OpenAlex counts 21 citations as of 18 November 2026, which puts it in the top 7% of works published in 2021 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Neuropharmacology.
- Citations
- 21
- Most cited in
- 2022 (5)
- Field-weighted impact
- 0.95
- References
- 72
- Authors
- 8
Abstract
The GluN2 subunits of N-methyl-d-aspartate receptors (NMDARs) are key drivers of synaptic plasticity in the brain, where the particular GluN2 composition endows the NMDAR complex with distinct pharmacological and physiological properties. Compared to GluN2A and GluN2B subunits, far less is known about the role of the GluN2D subunit in synaptic plasticity. In this study, we have used a GluN2C/2D selective competitive antagonist, UBP145, in combination with a GluN2D global knockout (GluN2D KO) mouse line to study the contribution of GluN2D-containing NMDARs to short-term potentiation (STP) and long-term potentiation (LTP) in the CA1 region of mouse hippocampal slices. We made several distinct observations: First, GluN2D KO mice have higher levels of LTP compared to wild-type (WT) mice, an effect that was occluded by blockade of GABA receptor-mediated inhibition or by using a strong LTP induction protocol. Second, UBP145 partially inhibited LTP in WT but not GluN2D KO mice. Third, UBP145 inhibited a component of STP, termed STP2, in WT but not GluN2D KO mice. Taken together, these findings suggest an involvement for GluN2D-containing NMDARs in both STP and LTP in mouse hippocampus.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Eapen, A. V., Fernández‐Fernández, D., Georgiou, J., Bortolotto, Z. A., Lightman, S. L., Jane, D. E., Volianskis, A., & Collingridge, G. L. (2021). Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices. Neuropharmacology, 201, 108833. https://doi.org/10.1016/j.neuropharm.2021.108833
MLA 9
Eapen, Alen V., et al. “Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices.” Neuropharmacology, vol. 201, 2021, p. 108833. https://doi.org/10.1016/j.neuropharm.2021.108833.
Chicago
Eapen, Alen V., Diego Fernández‐Fernández, John Georgiou, Zuner Assis Bortolotto, Stafford Louis Lightman, David E. Jane, Arturas Volianskis, and Graham L. Collingridge. 2021. “Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices.” Neuropharmacology 201: 108833. https://doi.org/10.1016/j.neuropharm.2021.108833.
Harvard
Eapen, A. V. et al. (2021) ‘Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices’, Neuropharmacology, 201, p. 108833. doi:10.1016/j.neuropharm.2021.108833.
IEEE
A. V. Eapen et al., “Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices,” Neuropharmacology, vol. 201, p. 108833, 2021, doi: 10.1016/j.neuropharm.2021.108833.
BibTeX
@article{eapen2021multiple,
title = {{Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices}},
author = {Eapen, Alen V. and Fernández‐Fernández, Diego and Georgiou, John and Bortolotto, Zuner Assis and Lightman, Stafford Louis and Jane, David E. and Volianskis, Arturas and Collingridge, Graham L.},
journal = {Neuropharmacology},
year = {2021},
volume = {201},
pages = {108833},
doi = {10.1016/j.neuropharm.2021.108833},
url = {https://doi.org/10.1016/j.neuropharm.2021.108833}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 2 | |
| 2022 | 5 | |
| 2023 | 2 | |
| 2024 | 4 | |
| 2025 | 4 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.95: it has been cited 0.95 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- GluN2D
- NMDA receptor
- short-term potentiation
- long-term potentiation
- synaptic plasticity
- hippocampus
- CA1
- GluN2A
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Eapen, A. V., Fernández‐Fernández, D., Georgiou, J., Bortolotto, Z. A., Lightman, S. L., Jane, D. E., Volianskis, A., & Collingridge, G. L. (2021). Multiple roles of GluN2D-containing NMDA receptors in short-term potentiation and long-term potentiation in mouse hippocampal slices. Neuropharmacology, 201, 108833. https://doi.org/10.1016/j.neuropharm.2021.108833
How many times has this paper been cited?
21 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Neuropharmacology: sign in and open the PDF from this page.
Who wrote this paper?
Alen V. Eapen, Diego Fernández‐Fernández, John Georgiou, Zuner Assis Bortolotto, Stafford Louis Lightman, David E. Jane, Arturas Volianskis, Graham L. Collingridge.
What is the DOI of this paper?
10.1016/j.neuropharm.2021.108833, permanently at https://doi.org/10.1016/j.neuropharm.2021.108833. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.